Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE5336.4532.35 (+0.61 %)

PREV CLOSE ( ) 5304.10

OPEN PRICE ( ) 5304.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2210

TODAY'S LOW / HIGH ( )5280.85 5360.45

52 WK LOW / HIGH ( )4498.9 6440

NSE5333.5032 (+0.6 %)

PREV CLOSE( ) 5301.50

OPEN PRICE ( ) 5323.50

BID PRICE (QTY) 5333.50 (1)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 237701

TODAY'S LOW / HIGH( ) 5277.00 5369.00

52 WK LOW / HIGH ( )4491.65 6439.9

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

33711.4

31437.5

33742.8

34146.7

Total Expenditure

26320.9

27524.6

26148.9

26618.4

PBIDT (Excl OI)

7390.5

3912.9

7593.9

7528.3

Other Income

1364.9

1459.6

929.9

1344.8

Operating Profit

8755.4

5372.5

8523.8

8873.09

Interest

297.8

284.2

360.3

281.4

Exceptional Items

129.3

0.00

PBDT

8586.9

5088.3

8163.5

8591.7

Depreciation

876.8

1124.9

852.8

789.1

Profit Before Tax

7710.1

3963.4

7310.7

7802.59

Tax

1026.9

733.3

902.8

783

Provisions and contingencies

Profit After Tax

6683.2

3230.1

6407.9

7019.59

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

6683.2

3230.1

6407.9

7019.59

Minority Interest

-36.5

-165.3

-149.7

-133.2

Shares of Associates

-4.1

-6.2

Other related items

Misc. Expenses Written off

Consolidated Net Profit

6642.6

3058.6

6258.2

6886.4

Equity Capital

239.1

Face Value (IN RS)

Reserves

Calculated EPS

55.56

25.58

52.34

57.60

Calculated EPS (Annualised)

222.25

102.33

209.39

230.41

No of Public Share Holdings

56151891

53651891

53010675

% of Public Share Holdings

46.96

44.87

44.34

PBIDTM% (Excl OI)

21.92

12.44

22.50

22.04

PBIDTM%

25.97

17.08

25.26

25.98

PBDTM%

25.47

16.18

24.19

25.16

PBTM%

22.87

12.60

21.66

22.85

PATM%

19.82

10.27

18.99

20.55

Notes

Risk Disclosures on Derivatives

Quarterly Results

ALKEM LABORATORIES LTD.